Verseon Corp
FREMONT, CA · CIK 0001348948 · Biotech · Private
AI-driven drug design and development platform for computational drug discovery
verseon.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $25M
- 7 Form D · Apr 2019
- 89 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201420152016201720182019
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $5,832,264 | |
| Private capital raised· 1 of 5 same day | Form D · SEC | $259,573 | |
| Private capital raised· 2 of 5 same day | Form D · SEC | $11,808,858 | |
| Private capital raised· 3 of 5 same day | Form D · SEC | $451,000 | |
| Private capital raised· 4 of 5 same day | Form D · SEC | $6,488,600 | |
| Private capital raised· 5 of 5 same day | Form D · SEC | $69,827 | |
| Private capital raised | Form D · SEC | $101,400 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2460 | Eidos Therapeutics | — | $26M |
| 2461 | Expesicor Inc | — | — |
| 2462 | Actym Therapeutics, Inc. | — | $25M |
| 2463 | Verseon Corp | — | $25M |
| 2464 | Pharmazz, Inc. | — | $25M |
| 2465 | Abzena plc | — | $4.3M |
| 2466 | CURADEL SURGICAL INNOVATIONS, INC. | — | $24M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Eniko FodorDirector · Executive Officer
- Thomas HechtDirector
- Sangtae KimDirector
- David KitaExecutive Officer
- Adityo PrakashDirector · Executive Officer
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.